skip to Main Content

To advance urologic care through computational and functional genomics:

– Deciphering mechanisms of response and resistance to therapy
– Establishing new models to define gene function and cell phenotypes
– Fostering a new generation of computational urologists

We are looking forward to growing our lab and community. If you want to learn more about our work, please reach out to us!


01.24.2024  Kate selected to present her single cell work at American Association for Cancer Research (AACR) Annual Meeting

01.19.2024  Filipe is the 2023 awardee of the BCAN Bladder Cancer Career Development Award

12.19.2023 Chris’s work selected for presentation at European Association of Urology Annual meeting in Paris

11.06.2023  Filipe promoted to Assistant Professor of Surgery, Harvard Medical School

05.31.2023  Konrad’s work presented at ASCO Annual Meeting 

04.20.2023  Welcome Kate!

For #trialtuesday, #CCTI_DFCI presents new trial 23-600 led by @FilipaLynce. IDE161, a PARG inhibitor, targets HRD and BRCA mutations in ER+ breast, endometrial, colorectal, and head and neck with these mutations. Different from PARPi. @DanaFarber

📢 BCAN's Young Investigator & Patient-Centered Clinical Research Awards are now open! Act fast – deadline 2/22/24. Secure $75,000 funding for one year. Click for details and apply: #ResearchFunding

Congratulations to @CarvalhoFilipeL of @BWHUrology, the recipient of BCAN's 2023 Career Development Award. Dr. De Carvalho's project will study overcoming resistance to chemo and IO in patients with MIBC .Click to read more:

Load More
Back To Top